ABEO's earnings report is right around the corner. Some more information:

Abeona Therapeutics (ABEO) is reporting earnings on July 27. Lets zoom in on how the stock is performing.

Analysts think Abeona Therapeutics will report an EPS (earnings per share) of -0.68.

As of July 19 shares of ABEO are trading at $4.7. Over the last 52-week period, the price is down -23.33%. A larger move here can mean investors will have a stronger bullish or bearish outlook on the stock.

There are two primary things that ABEO bulls will be concerned with. The first is that the reported EPS beat the estimates of analysts. Stocks respond favorably to that news. The second is that the report outlines a positive growth story for the stock in the coming quarters.

When they're finished harrassing campers, chasing hikers, or Mauling Leonard DiCaprio in the Revenant, ABEO bears will be listening for news that the company underperformed the analysts' estimates. They'll also want to hear about a negative growth story that frames the company's future as one of deceleration or even decline in revenues over the following quarters.

Whether you're a bear or bull you'll want to be aware that occasionally a stock's price movement is caused by the analysts' estimates, rather than from the earnings report itself. As you see more of these, you'll begin to notice patterns in the runup and rundown of the stock's price.